Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2032 of 5804
-
Heart patients may soon skip clinic visits with new remote monitoring trial
Disease control OngoingThis is a Canadian multicenter randomized controlled trial to assess remote patient management. Patients will be randomized to remote patient management with VIRTUES versus usual care, and will be stratified by RemoteView vs no RemoteView utilization, as well as by center.
Phase: NA • Sponsor: Ratika Parkash • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Pressurized oxygen shows promise for severe COVID-19 in small trial
Symptom relief CompletedThe 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic.So far, no specific treatment has proven efficacy. Recent case series reported the use of Hyperbaric Oxygen Therapy (HBOT) on 5 severe COVID-19 patients who developed respiratory insufficiency. HBOT mecha…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Promising combo tackles rare lymphoma in early trial
Disease control CompletedThis is a prospective single arm, multi-center, phase II clinical trial to observe the efficacy and safety of VR-CAP (Bortezomib and Rituximab-Cyclophosphamide, Epirubicin and Prednisone) in the first-line treatment for patients with marginal zone lymphoma.
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
What happens to the immune system after COVID-19? a major study aims to find out.
Knowledge-focused Recruiting nowLIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specime…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Malaria drug combo shows promise against COVID-19 in early trial
Disease control TerminatedThis study will evaluate anti-malarial/anti-infective single-agent and in combination for patients with confirmed COVID-19 infection. The first combination to be evaluated is atovaquone and azithromycin.
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New antibody takes aim at Hard-to-Treat cancers
Disease control OngoingIn phase Ia study, the safety and tolerability of SI-B001 in patients with locally advanced or metastatic epithelial malignancies will be investigated to determine the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) of SI-B001. In the phase Ib study, the safety and to…
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
COVID prevention drugs fail in hospital worker trial
Prevention CompletedThe Investigators propose to set up a preventive trial of infection in hospital workers at risk of coronavirus infection by comparing the rate of SARS-Cov-2 infection in a population of negative SARS-Cov-2 hospital workers receiving preventively azithromycin, hydroxychloroquine o…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Spit test could replace swabs for COVID-19 diagnosis
Diagnosis CompletedThe objective of the study is to develop and validate a molecular diagnostic strategy (RT-ddPCR multiplex) of COVID-19 based on a saliva sample and alternative to the RT-qPCR method, in order to : 1. to compensate for the risk of a shortage of diagnostic kits, reagents and mater…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated Jun 27, 2026 12:09 UTC
-
Lying face-down with high-flow oxygen may help COVID-19 patients avoid breathing tubes
Knowledge-focused CompletedA subset of patients with COVID-19 develops acute respiratory failure and acute respiratory distress syndrome (ARDS) (1). The use of invasive mechanical ventilation for the treatment of these conditions is associated with high mortality rates (2,3). The use of high-flow nasal oxy…
Sponsor: Hospital Privado de Comunidad de Mar del Plata • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New saliva test could diagnose COVID-19 in under an hour
Diagnosis CompletedCoronavirus disease 2019 or COVID-19 is a highly contagious infectious disease. Symptoms of the disease are non-specific (fever, cough, dyspnea and fatigue), common with many seasonal viruses, which complicates the diagnosis. For mild forms, which represent the vast majority of c…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
COVID-19 ICU survivors may face unique long-term disabilities, study suggests
Knowledge-focused OngoingThe investigators hypothesize that those with respiratory failure due to COVID-19 will have different burdens of mental and physical disability than those with respiratory failure who do not have COVID-19. Detecting these potential differences will lay an important foundation for…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Massive proton therapy registry aims to unlock secrets of cancer treatment
Knowledge-focused Recruiting nowThe Johns Hopkins Proton Therapy center is establishing a registry to capture the full 3D radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The goal is to have all patients treated at the proton center to be …
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Psoriasis drug shows promise for heart health in small study
Disease control CompletedPsoriasis, a common chronic inflammatory skin disease affecting approximately 2% of the population, is associated with increased cardiovascular (CV) risk. Despite the implication of inflammation in this excess risk, it remains unclear whether reducing inflammation reduces the ris…
Phase: PHASE4 • Sponsor: Marcelo F. Di Carli, MD, FACC • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New study tracks how well larotrectinib works in everyday cancer care
Knowledge-focused Recruiting nowIn this observational study researcher want to learn more about the effectiveness of drug VITRAKVI (generic name: larotrectinib) and how well the drug is tolerated during routine use in patients with TRK fusion cancer which is locally advanced or spread from the place where it st…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Flu drug cocktail shows promise in hospitalized patients
Disease control CompletedThis is a randomized, double-blind, placebo-controlled Phase 2-like, investigator-directed trial of hospitalized patients with laboratory confirmed influenza. Eligible and consented patients will be randomly assigned, in a 1:1 ratio, to one of two groups: Group 1, the combination…
Phase: PHASE2, PHASE3 • Sponsor: Bassett Healthcare • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Heart attack test gets a Tune-Up: new method aims to cut false positives
Diagnosis Recruiting nowTroponin T (TnT) is a part of the troponin protein complex that principally exists in cardiac and skeletal muscle cells and is widely used as diagnostic biomarker for myocardial injury and, thus, myocardial infarction (MI). Elevated TnT levels can, however, be observed in the pre…
Sponsor: University of Turku • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
New combo drug trial hopes to tame tough breast cancer
Disease control OngoingThe primary objective of this study is to evaluate the safety and tolerability of H3B-6545 and palbociclib when administered in combination in order to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of this combination in women with advanced…
Phase: PHASE1 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Massive study reveals COVID-19's toll on cancer patients
Knowledge-focused CompletedRoutinely collected data will be used to assess the morbidity and mortality of cancer patients following a positive COVID-19 infection.
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Common surgery antibiotics may trigger confusion in seniors
Knowledge-focused CompletedThis study aimed to characterize the current patterns of perioperative prophylactic antibiotic use and to systematically evaluate the association between different antibiotic classes and the occurrence of POD, thereby providing clinically relevant safety evidence for perioperativ…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Heart device for preemies under scrutiny in new safety study
Disease control OngoingThe purpose of this post-marketing clinical use database surveillance is to observe the frequency, type, and degree of adverse device effects and adverse events in order to assure the safety of the medical device, and to collect safety and efficacy information for evaluating the …
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC